RARE Ultragenyx Pharmaceutical Inc.

NASDAQ
$14.46

Ultragenyx Pharmaceutical Inc. (RARE) Institutional Ownership

What the institutions did with RARE last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended September 30, 2026.

Managers compared
3
filed both this quarter and last
Managers holding
2
-1 on the quarter
Buyers
2
0 opened new
Sellers
1
1 sold out entirely
Buyer share
66.7%
of managers who traded it
Breadth
+33.3
net buyers, as a share of those trading

Only 3 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Versant Capital Management, Inc 2.6K 78.6%
MassMutual Private Wealth & Trust, FSB 695 21.4%

Largest changes

Manager Action Previous Current Change
Versant Capital Management, Inc Increased 1.2K 2.6K +1.4K
MassMutual Private Wealth & Trust, FSB Increased 60 695 +635
CX Institutional Sold Out 135 0 -135

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.